A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The settlement, in principle, would not shield Purdue Pharma or the Sackler family from additional liability over their role in the opioid crisis.

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...

Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families." ...

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...